| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vera Therapeutics, Inc. (VERA) has 18 insiders with recent SEC Form 4 filings, including 4 buys and 0 sells. VERA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 137.5K | $4.98M | - | |
| Other | 53.1K | $1.92M | - | |
| Other | 50.0K | $1.81M | - | |
| CFO | 50.0K | $1.81M | - | |
| Other | 49.1K | $1.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2021 | Longitude Capital Partners Iv, LLC63 | 10% Owner | Buy | 909,090 | $11.00 | $9,999,990.00 | +41.6% | +37.7% | +32.9% | |
| May 18, 2021 | Emster Kurt Von62 | Director | Buy | 790,555 | $11.02 | $8,714,653.25 | +36.1% | +37.7% | +32.9% | |
| May 18, 2021 | Abingworth LLP | 10% Owner | Buy | 772,727 | $11.00 | $8,499,997.00 | +35.3% | +37.7% | +32.9% |